Keith’s note: THIS research by Auxilium Biotechnologies is exactly what the Space Station can do and is a preview of what space-based research can offer. I was pushing these sorts of research as part of my job at NASA back in the 90s – even before 3d bioprinting.
“Auxilium Biotechnologies today announced a major milestone in space biomanufacturing with the successful bioprinting of kidney and liver tissues aboard the International Space Station (ISS), marking the first time either tissue type has been manufactured in space. Auxilium’s bioprinted biological tissues and nerve repair implants returned to earth on Mission AXLM-3 that flew on NASA’s SpaceX CRS-34 and splashed down off the California coast on June 17th, 2026, at 5:11am Pacific.
During the mission, Auxilium’s AMP-1 orbital bioprinter successfully manufactured kidney, liver, and cartilage tissues while also producing 28 nerve repair implants. The achievement represents the first demonstration of kidney tissue manufacturing in space, the first demonstration of liver tissue manufacturing in space, and the first mission to manufacture three distinct tissue types during a single spaceflight. The production of multiple tissue types and clinically relevant nerve repair implants represents the first demonstration of a scalable, multi-product biomanufacturing platform in space.”
